GlassScriptPhysician profile
Bruce K Lowell
NPI 1912004805
$14,319.36
in general payments reported to CMS, 2019-2025
58 companies · $2,665 in 2025
The $2,665 reported for 2025 was more than what 96% of Geriatric Medicine (Internal Medicine) providers received nationally (typical 2025 total: $123).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,842 · 2020: $602 · 2021: $620 · 2022: $2,092 · 2023: $3,046 · 2024: $2,451 · 2025: $2,665.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,007 · Education: $156.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,007.28 |
| Education | $155.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $1,282.41 | 2019-2025 | Veozah, Myrbetriq |
| Amgen INC. | $1,265.76 | 2019-2025 | Repatha, Otezla, Otezla |
| Astrazeneca Pharmaceuticals LP | $1,248.27 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Abbvie INC. | $1,029.74 | 2019-2025 | |
| Novo Nordisk INC | $983.19 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Lilly USA, LLC | $825.60 | 2019-2025 | Mounjaro, Zepbound, Kisunla |
| Janssen Pharmaceuticals, INC | $814.32 | 2019-2025 | Spravato |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $542.63 | 2022-2025 | Xifaxan, Trulance |
| Antares Pharma, INC. | $465.93 | 2019-2025 | Xyosted, Tlando, Nocdurna |
| Novartis Pharmaceuticals Corporation | $433.70 | 2019-2025 | |
| Pfizer INC. | $394.65 | 2019-2025 | |
| Eisai INC. | $313.62 | 2019-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $288.45 | 2024-2025 | Caplyta |
| Sanofi-Aventis U.S. LLC | $280.83 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $239.60 | 2019-2024 | Jardiance, Synjardy, Tradjenta |
Show all 58 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $236.32 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $233.85 | 2019-2020 | |
| Abbott Laboratories | $214.04 | 2022-2024 | Freestyle Libre 3 |
| Ardelyx, INC. | $205.75 | 2024-2025 | Ibsrela |
| Ibsa Pharma INC. | $187.41 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $186.57 | 2019-2022 | |
| Corium, LLC | $172.53 | 2022-2023 | Adlarity |
| Sumitomo Pharma America, INC. | $171.35 | 2025 | Gemtesa |
| E.R. Squibb & Sons, L.L.C. | $166.72 | 2021-2025 | Eliquis |
| Tolmar, INC. | $158.41 | 2024-2025 | Jatenzo |
| Regeneron Healthcare Solutions, INC. | $152.00 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $150.08 | 2022-2024 | Livalo, Seglentis |
| Halozyme INC | $133.70 | 2023 | |
| Radius Health, INC. | $125.23 | 2023-2024 | Tymlos |
| Avanir Pharmaceuticals, INC. | $119.28 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $108.83 | 2019-2020 | |
| Allergan, INC. | $103.69 | 2019-2020 | |
| Otsuka America Pharmaceutical, INC. | $99.52 | 2023-2025 | Nuedexta, Rexulti |
| Esperion Therapeutics, INC. | $86.06 | 2024-2025 | Nexletol |
| Mylan Specialty L.P. | $80.94 | 2022-2024 | Yupelri |
| Exact Sciences Corporation | $78.26 | 2023-2024 | Cologuard Collection Kit |
| Celgene Corporation | $78.18 | 2019 | |
| Genentech USA, INC. | $69.54 | 2019-2022 | |
| Glaxosmithkline, LLC. | $62.31 | 2019-2020 | |
| Mimedx Group, INC. | $53.04 | 2024-2025 | |
| Renalytix Ai, INC. | $45.71 | 2024 | Kidneyintelx Blood Collection Convenience Kit |
| Intra-Sana Laboratories | $40.46 | 2023 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Vivus LLC | $37.00 | 2019 | |
| Baxter Healthcare | $34.35 | 2024 | Hillrom - Connex Spot Monitor |
| Corcept Therapeutics | $30.85 | 2025 | Korlym |
| Clarus Therapeutics INC. | $30.57 | 2021 | |
| Irhythm Technologies, INC. | $26.54 | 2024 | Zio Xt Patch, Zio Monitor |
| Insightec,INC | $24.81 | 2025 | Exablate |
| Inspire Medical Systems, INC. | $24.20 | 2025 | Inspire |
| Vertical Pharmaceuticals, LLC | $23.06 | 2019 | |
| Idorsia Pharmaceuticals US INC | $22.91 | 2023 | Quviviq |
| Ironwood Pharmaceuticals, INC | $22.78 | 2019 | |
| Genzyme Corporation | $21.78 | 2019 | |
| Ars Pharmaceuticals Operations, INC. | $19.87 | 2025 | Neffy |
| Valinor Pharma, LLC | $19.75 | 2023 | Movantik |
| Acerus Pharmaceuticals Corporation | $18.05 | 2022 | |
| Amneal Pharmaceuticals LLC | $17.45 | 2023 | Unithroid |
| Aytu Biopharma, INC. | $16.91 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bruce Lowell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.